C.D.A (Coen) Stehouwer MD, PhD (born Rotterdam, 1960 ) currently is Professor of Internal Medicine and Chair of the Department of Internal Medicine at Maastricht University in the Netherlands. He is also an upcoming board member of the European Association for the Study of Diabetes (EASD).

He is a clinician-scientist in the fields of diabetology and microcirculatory as well as large artery research.

Since 1990, the work of Professor Stehouwer and his group has led to 83 completed PhD theses, and more than 800 peer-reviewed papers in international journals.  His work is well-recognized as shown by a Hirsh index of 117 (Web of Science); >62,000 citations; several awards, such as the Dr. F. Gerritzen Award for excellent diabetes research (Dutch Diabetes Research Foundation, 1993); the Castelli-Pedroli Award for excellent research into the complications of diabetes (European Association for the Study of Diabetes, 2005); the Dutch Society of  Vascular Medicine Career Award (2007); the Ruitenga Van Swieten honorary professorship of the University of Amsterdam (2009); membership of the Faculty of 1000 (2009); the Donald McDonald Award of Artery Society (2017); as well as invited lectures at (inter)national meetings, such as those of the European Society for the Study of Diabetes, the American Diabetes Association, the European Society for Microcirculation, the World Congress for Microcirculation, the European Society for Cardiology, and the American Heart Association.

His research programme focuses on the elucidation of how metabolic changes in (pre)diabetes and the metabolic syndrome cause micro- and macrovascular disease. A key element of the programme is to combine epidemiology, clinical physiology and experimental approaches, in the conviction that these approaches should complement and mutually inspire each other. He is one of the principal investigators of the well-known Hoorn Study  (since 1992). He also obtained national and European funding (M€ 16) for, and is the initiator and Scientific Director of, the Maastricht Study (started 2010), which combines very detailed phenotyping with an ‘omics’ approach in 7000 individuals without and 2000 with type 2 diabetes to elucidate how diabetes leads not only to classic complications but also to so-called emerging complications such as cognitive dysfunction, mood disorders, liver disease, musculoskeletal disease, pulmonary disease, sleep-disordered breathing, and infectious diseases.

Professor Stehouwer in addition is an experienced teacher, mentor and coach, and Editor-in-Chief of the Dutch Textbook of Internal Medicine (since 1996; 15th edition, 2017).  

Selected administrative roles, in reverse order

2018-current Member of the Health Council of the Netherlands

2016 Chair, National Science Agenda, Section Diagnosis and Treatment

2011-current Board Member, Cardiovascular Research Institute Maastricht 

2010-2016 Board Member, Dutch Society of Internal Medicine

2008-current President, De Drie Lichten Charity Fund (biomedical science)

2006-2019 Director, residency program, Internal Medicine, Maastricht University Medical Centre+ (MUMC+)

2005-current Director, Division of Chronic Diseases, MUMC+ (~600 staff)

2004-current Chair, Department of Internal Medicine, MUMC+  

2002-2004 Director, Institute for Cardiovascular Research, VU medical centre,Amsterdam (VUmc)

2002-2004 Director, residency program, Vascular Medicine, VUmc

2000-2004 Deputy director, residency program, Internal Medicine, VUmc

2000-2004 Vice-chair, Department of General Internal Medicine, VUmc

1998-2007 President, Dutch Society of Vascular Medicine